Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Steve Yang to join AstraZeneca as head of Asia and emerging markets R&D

This article was originally published in Scrip

Executive Summary

Dr Steve Yang has been named vice-president and head of R&D for Asia and emerging markets at AstraZeneca, effective 6 January. Dr Yang, previously a vice-president and head of Asia R&D for Pfizer, will continue to be based in Shanghai and report to Martin Mackay, AstraZeneca's R&D president. Part of his responsibilities at Pfizer included building up Asia-Pacific partnerships with academia, biotech ventures and contract research organisations to tap into regional research expertise (, 6 July 2010). Dr Yang is also a co-founder of the BayHelix group, a network of Chinese life science business leaders.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts